Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2002 April;68(4) > Minerva Anestesiologica 2002 April;68(4):252-6

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036


eTOC

 

INFECTIONS  SMART 2002 Milan, May 29-31, 2002


Minerva Anestesiologica 2002 April;68(4):252-6

language: English

Markers of hyperinflammation

Gerlach M., Gerlach H.

From the Klinik für Anaesthesiologie und Operative Intensivmedizin Vivantes-Klinikum Neukoelln Berlin, Germany


FULL TEXT  


The inflammatory events responsible for clinical derangements such as severe infection, sespsis, or septic shock are thought to be similar. Defining different mediators of inflammatory response, and describing failures of multiple immunomodulator studies to reduce morbidity and mortality of clinical sepsis, the author reconsiders the pathogenesis of sepsis. Septic patients may undergo various stages of disease. In each stage a pro- or a anti-inflammatory process may be predominant. Moreover different subgroups of infection, e.g. fungal sepsis, have different characteristics compared to bacterial infection. Future experiments and clinical trial may help defining circustances under which inhibiting or augmenting endogenous mediators may be a helpful adjunctive therapy for sepsis.

top of page

Publication History

Cite this article as

Corresponding author e-mail